Cart
sales@molnova.com
M4205
CAS No. 2590556-80-0
M4205( —— )
Catalog No. M28834 CAS No. 2590556-80-0
M4205 is an inhibitor of c-Kit exhibiting high activity on c-Kit mutations in exons 11, 13, 17.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 222 | Get Quote |
|
| 10MG | 357 | Get Quote |
|
| 25MG | 597 | Get Quote |
|
| 50MG | 851 | Get Quote |
|
| 100MG | 1152 | Get Quote |
|
| 500MG | 2313 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameM4205
-
NoteResearch use only, not for human use.
-
Brief DescriptionM4205 is an inhibitor of c-Kit exhibiting high activity on c-Kit mutations in exons 11, 13, 17.
-
DescriptionM4205 is an inhibitor of c-Kit exhibiting high activity on c-Kit mutations in exons 11, 13, 17.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
Targetc-Kit
-
RecptorRARγ|RARβ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2590556-80-0
-
Formula Weight508.62
-
Molecular FormulaC29H32N8O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 5 mg/mL (9.83 mM)
-
SMILESN=1C=NC(=CC1NCC=2C=CC(=CC2)C=3C=NN(C3)C)C4=CN=C5C=C(OCCCN6CCCC6)C=CN54
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kim MJ, et al. The role of specific retinoid receptors in sebocyte growth and differentiation in culture. J Invest Dermatol. 2000 Feb;114(2):349-53.
molnova catalog
related products
-
Amuvatinib
A novel RTK inhibitor that effectively inhibits c-Kit, PDGFRα and Flt3 with IC50 of 10 nM, 40 nM and 81 nM, respectively.
-
CS-2660
CS-2660, a highly selective, orally available, well tolerated VEGFR2 inhibitor with IC50 of 40 nM, inhibits closely related tyrosine kinases such as Ret and Kit with IC50 of 180 nM and 500 nM.
-
RGB-286638 free base
RGB-286638 free base is a novel CDK inhibitor.
